Northwestern Medicine researchers uncover molecular drivers of lymphedema, shedding light on potential treatments for this chronic condition.
- Northwestern Medicine scientists have discovered molecular mechanisms underlying lymphatic valve development, which could lead to new treatments for lymphedema.
- Lymphedema is a chronic condition that causes swelling and currently has no cure, affecting one in 100,000 individuals in the U.S.
- Research focused on understanding how genetic mutations associated with lymphedema contribute to the disease.
- Studies on mice missing specific genes revealed insights into how a healthy lymphatic system develops and how genetic variations can lead to lymphedema.
- The findings provide valuable information on the genetic regulation of lymphatic function and the molecular pathways involved in lymphedema, with potential implications for future treatment strategies.
Source link
Dermatology,Oncology,Rheumatology